Bicara Therapeutics Inc. (BCAX) income statement
BCAXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$8.44−0.68 (-7.46%)
Close on Nov 20, 2026Market cap $558.50MP/E –Yield –
Bicara Therapeutics Inc. financial ratios
See a number that looks wrong?